/
HOPHF
$2.33+$1.09 (+87.90%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.33 – $2.33
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-0.03
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $348.3K | $421.8K | $350.7K | $283.6K | $2.6M | $1.7M | $799.8K | $929.9K |
| Gross profit | −$348.3K | −$421.8K | −$350.7K | −$283.6K | −$2.6M | −$1.7M | −$799.8K | −$929.9K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $73 | $28 | $114 | $51 | $487 | $91 | $236.7K | $0 |
| Operating income | −$1.7M | −$1.7M | −$2.2M | −$2.7M | $4.0M | −$6.5K | −$5.4M | −$7.0M |
| EBITDA | −$1.6M | −$1.6M | −$2.0M | −$2.6M | −$4.9M | −$5.3K | −$5.1M | −$8.9M |
| Net income | −$1.5M | −$1.5M | −$2.1M | −$5.1M | −$4.0M | −$6.7K | −$5.6M | −$9.8M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -1.72 | -1.61 | -2.01 | -2.64 | -1.62 | -2.37 | -2.13 | -2.20 |
Annual figures · source: Financial Modeling Prep
Peer comparison
HEMOGENYX PHARMA PLC
HEMOGENYX PHARMA PLC
Held by traders on TradeandTell
No one on the platform currently holds HOPHF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HOPHF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-12-13 | 1-for-400reverse |
Recent trades on TradeandTell
No one on the platform has traded HOPHF yet.